CBWTF - Auxly Cannabis Group Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.905
-0.055 (-5.73%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.960
Open0.958
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.860 - 0.979
52 Week Range0.560 - 2.700
Volume3,418,628
Avg. Volume1,943,259
Market Cap523.209M
Beta (3Y Monthly)9.43
PE Ratio (TTM)N/A
EPS (TTM)-0.089
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIRE4 days ago

    Non-Opioid Pain Solutions Set to Make Investors Major Gains

    HENDERSON, NV / ACCESSWIRE / October 17, 2018 / Below are a few opportunities to help with one of America's largest problems: opioid addiction.While cannabis stocks have been receiving a lot of the attention ...

  • ACCESSWIRE6 days ago

    Auxly Cannabis Business Model, Verticals and Operational Highlights

    NEW YORK, NY / ACCESSWIRE / October 15, 2018 / Traders News Source, a leading independent equity research, and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Auxly Cannabis Group Inc. (CBWTF), a company executing a business plan of building a vertically integrated global cannabis company with assets in each key segment of the cannabis value chain as the Canadian market enters legalization of recreational cannabis on October 17, 2018. As the start date for legal cannabis in Canada drew nearer the company shares rose to the current level of $.92 and have been as high as $1.10. The Company has continued to acquire cultivation capacity by developing cannabis cultivation facilities in Canada and internationally.

  • Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group
    Motley Fool7 days ago

    Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group

    Is bigger better in a battle between these two Canadian marijuana stocks?

  • 4 Top Marijuana Penny Stocks for the Rest of 2018
    InvestorPlace12 days ago

    4 Top Marijuana Penny Stocks for the Rest of 2018

    While it’s open to debate whether President Donald Trump made America great, the 2016 election did produce one undeniable result: it laid the foundation for cannabis-related businesses, thereby dramatically improving profitability potential for marijuana penny stocks. With so many states reporting budget deficits, the last thing the embattled Trump administration wants to do is to stymie economic progress.

  • GlobeNewswirelast month

    Auxly Announces Strategic Investment in FSD Pharma

    Pursuant to the Transaction, Auxly has subscribed for $7,500,000 of publicly traded Class B Subordinate Voting Shares of FSD at a price of $1.00 per share (“Purchased Shares”). Proceeds from the financing will be used to fund the ongoing construction of the initial 220,000 square feet of cultivation space that Auxly and FSD are jointly developing at FSD’s 620,000 square foot facility (the “Facility”) in Cobourg, Ontario pursuant to the agreed upon construction and development budget, announced on July 3, 2018. Auxly retains a 49.9% stream of all cannabis and cannabis-derived products produced at the Facility, under partnership with Auxly, in perpetuity.

  • GlobeNewswirelast month

    REPEAT - Auxly Cannabis Group and Kaneh Bosm BioTechnology Inc. Announce Strategic Investment and Partnership and Name Change of KBB to ICC International Cannabis Corp.

    Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") and Kaneh Bosm BioTechnology Inc. (CSE:KBB)(8K51.F)(KNHBF) ("Kaneh Bosm") are pleased to announce that Auxly has completed a strategic investment (the “Investment”) and has entered into a commercial rights agreement (the “Agreement” and together with the Investment, the “Transaction”) with Kaneh Bosm. Kaneh Bosm, through its subsidiaries, has a number of agreements and licences in place related to pharmaceutical distribution, wholesale importation, research and development, cultivation, production, storage, and exportation of cannabis and cannabis derivatives. In particular, Kaneh Bosm has agreements in place to supply a European-based pharmaceutical distributor with a network of 35,000 pharmacies in 16 countries, in addition to working interests in industrial hemp licences in Greece and wholly-owned licences to cultivate, produce, distribute, store, and export cannabis in Colombia, the Kingdom of Lesotho, and Denmark.

  • GlobeNewswirelast month

    Auxly Cannabis Group and Kaneh Bosm BioTechnology Inc. Announce Strategic Investment and Partnership and Name Change of KBB to ICC International Cannabis Corp.

    Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") and Kaneh Bosm BioTechnology Inc. (CSE:KBB)(8K51.F)(KNHBF) ("Kaneh Bosm") are pleased to announce that Auxly has completed a strategic investment (the “Investment”) and has entered into a commercial rights agreement (the “Agreement” and together with the Investment, the “Transaction”) with Kaneh Bosm. Kaneh Bosm, through its subsidiaries, has a number of agreements and licences in place related to pharmaceutical distribution, wholesale importation, research and development, cultivation, production, storage, and exportation of cannabis and cannabis derivatives. In particular, Kaneh Bosm has agreements in place to supply a European-based pharmaceutical distributor with a network of 35,000 pharmacies in 16 countries, in addition to working interests in industrial hemp licences in Greece and wholly-owned licences to cultivate, produce, distribute, store, and export cannabis in Colombia, the Kingdom of Lesotho, and Denmark.

  • ACCESSWIRElast month

    These Companies Bring Together Tech, Energy & Cannabis

    HENDERSON, NV / ACCESSWIRE / September 13, 2018 / The stock market is often divided into eleven major sectors representing key areas of the economy. Within each sector, there are a number of different ...

  • GlobeNewswirelast month

    Auxly Provides Operational Update on Uruguay-Based Inverell S.A.

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to provide the following operational update on the Company’s operations in Uruguay conducted through Inverell S.A. (“Inverell”). Inverell, founded and operated by Dr. Raul Urbina, a world-renowned expert in large scale outdoor cultivation, micropropagation, plant breeding and extraction operations, is a federally licensed cannabis operator based in Montevideo, Uruguay.

  • ACCESSWIRElast month

    3 Canadian Marijuana Stocks Continuing to Trade Higher in September

    CORAL GABLES, FL / ACCESSWIRE / September 11, 2018 / Canadian marijuana stocks continue to lead the sector as the October deadline looms. In roughly 1 month Canada will begin legal sale of recreational marijuana across the country but this is just the beginning for the country. The move by Canada effectively makes the country the first G7 nation to legalize recreational cannabis use and further opens opportunities for companies in Canada to export marijuana as well.

  • GlobeNewswirelast month

    Auxly and Lotus Ventures Announce Investment and Signing of Definitive Long Term Purchase and Sale Agreement

    Auxly Cannabis Group Inc. (TSX.V - XLY) (CBWTF) ("Auxly" or the "Company") and Lotus Ventures Inc. (CSE – J)(“Lotus”) are pleased to announce the closing of an additional investment by Auxly to partially fund the completion of Lotus’ 22,500 square foot Facility (the “Facility”) in Armstrong, British Columbia (the “Transaction”). Lotus is a late stage applicant pursuant to the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) and anticipates completing the construction of the Facility by the end of September 2018. Pursuant to the Transaction, which is in addition to Auxly’s $1,000,000 subscription of common shares of Lotus completed in January 2018, Auxly advanced an additional $4,000,000 to Lotus to partially fund the completion of the Facility.

  • GlobeNewswirelast month

    Auxly Provides Corporate Update and Highlights 2018 Milestones

    Auxly Cannabis Group Inc. (TSX.V - XLY) (CBWTF) ("Auxly" or the "Company") is pleased to provide a corporate update in respect of its key milestones in 2018.  The Company continues to move forward and execute its business plan of building a vertically integrated global cannabis company. Originally founded with the primary intent of providing financing solutions to licensed producers and licensed producer applicants, the Company has since evolved into a global cannabis company with assets in each key segment of the cannabis value chain. The Company remains confident in its business strategy as the Canadian market enters legalization of recreational cannabis on October 17, 2018.

  • GlobeNewswirelast month

    Auxly Announces Definitive International Supply Agreement With Aphria

    Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX - CBWTF) ("Auxly" or the "Company") is pleased to announce that further to its previously announced interim supply agreement on January 17th, 2018, the Company, through its wholly owned subsidiary Dosecann Inc. (“Dosecann”), has entered into a definitive supply agreement (the “Agreement”) with Aphria Inc. (“Aphria”). Pursuant to the Agreement, Dosecann will have the option to purchase cannabis, including dried flower and cannabis oil (collectively, “Cannabis Products”) for distribution to certain international markets, including Mexico, Portugal, and Serbia, as well as a limited amount for distribution into the Canadian market.

  • GlobeNewswirelast month

    Auxly and Delta 9 Announce Strategic Investment and Supply Agreement

    Auxly Cannabis Group Inc. (TSX.V - XLY) (CBWTF) ("Auxly") and Delta 9 Cannabis Inc. (TSX.V -NINE) (“Delta 9”) are pleased to announce that the parties have entered into definitive agreement (the “Agreement”) whereby Auxly will make a strategic investment to fund the expansion of Delta 9’s licensed cannabis cultivation facility in Winnipeg, Manitoba (the “Facility”) and provide general working capital to Delta 9. Pursuant to the Agreement, Auxly has subscribed for 5,909,090 common shares of Delta 9 (each a “Delta 9 Share”) at a price of $2.75 per Delta 9 Share, representing a total investment of $16,250,000.

  • GlobeNewswire2 months ago

    Auxly Announces Completion of KGK Science Acquisition

    Auxly Cannabis Group Inc. (TSX.V - XLY) (CBWTF) ("Auxly" or the "Company") is pleased to announce that, further to its press release issued on August 21, 2018, it has completed its previously announced acquisition of all of the outstanding shares of KGK Science Inc. (“KGK”). KGK is a leading health and wellness focused private contract research organization based in London, Ontario, having provided a variety of clinical services to many of North America’s leading nutraceutical, natural health product and consumer packaged goods companies. The Company expects to leverage KGK’s expertise and research abilities to further the Company’s cannabinoid-based product development efforts through collaboration with the Company’s wholly owned subsidiary, Dosecann Inc.

  • GlobeNewswire2 months ago

    Auxly Announces Acquisition of Leading Canadian Contract Research Organization KGK Science

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that it has entered into a share purchase agreement (the “Share Purchase Agreement”) with KGK Science Inc. (“KGK”) to acquire all of the issued and outstanding shares of KGK (the “KGK Shares”) for total consideration of $12,300,000 payable in cash and common shares of the Company. KGK is a leading health and wellness focused private contract research organization based in London, Ontario, and the Company expects to leverage KGK’s expertise and research abilities to further the Company’s product development efforts through collaboration with the Company’s wholly owned subsidiary, Dosecann Inc. (“Dosecann”).

  • GlobeNewswire2 months ago

    Auxly Announces Product Strategy Update and World-Class Additions to Dosecann's Management Team

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to provide an update on the product strategy of the Company’s wholly owned subsidiary, Dosecann Inc. (“Dosecann”), as well as a number of strategic additions to the management team of Dosecann. Dosecann, Auxly’s cornerstone midstream asset that is Canada’s largest cannabis specific “Licensed Dealer”, is positioned to play a significant role as a leading research, product development, extraction, formulation and consumer packaged goods manufacturing center in the Canadian cannabis industry with its 42,000 square foot purpose-built facility in Charlottetown, PEI. As previously announced, Dosecann has successfully obtained a Dealer’s Licence for Controlled Drugs and Substances (the “Licence”) from Health Canada and has commenced operations related to the creation of value-added cannabis products, as permitted by the Licence and applicable laws.

  • GlobeNewswire2 months ago

    Auxly Announces Strategic Partnership With Cannabis OneFive

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that it has entered into a strategic partnership with Cannabis OneFive, Inc. (“C15”), a provider of quality management and document control software systems for the cannabis industry. Auxly’s wholly-owned subsidiary, Dosecann Inc. (“Dosecann”), will become a lead subscriber of C15’s software, and the Company expects the C15 software to be deployed at other Auxly facilities. In connection with the strategic partnership, the Company has entered into a share exchange agreement (the “Share Exchange Agreement”) with C15.

  • GlobeNewswire2 months ago

    Auxly Announces Receipt of Dealer’s Licence for Dosecann Facility

    Auxly Cannabis Group Inc. (XLY.V) ("Auxly" or the "Company") is pleased to announce that the Company’s wholly-owned subsidiary, Dosecann Inc. (“Dosecann”), has successfully obtained a Dealer’s Licence for Controlled Drugs and Substances (the “Licence”) from Health Canada pursuant to the Narcotics Control Regulations for Dosecann’s purpose built 42,000 square foot facility located in Charlottetown, PEI.

  • The Craziest Marijuana Statistic From July
    Motley Fool2 months ago

    The Craziest Marijuana Statistic From July

    It was a rough month to be a pot-stock investor.

  • 8 Pot Stocks That Can Rise Above Marijuana Controversies
    InvestorPlace3 months ago

    8 Pot Stocks That Can Rise Above Marijuana Controversies

    Right now, the biggest trends in the markets are artificial intelligence, the blockchain and marijuana. Of these, marijuana represents the subject matter about which investors should know the most. After all, marijuana has been around as long as man has walked the earth.

  • The Under-the-Radar Reason Marijuana Stocks Are Plunging
    Motley Fool3 months ago

    The Under-the-Radar Reason Marijuana Stocks Are Plunging

    These three growers provide pretty clear evidence as to why pot stocks are swooning.

  • GlobeNewswire3 months ago

    Auxly Congratulates Strategic Partner Inner Spirit on Initial Public Offering and Files Early Warning Report

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly"), is pleased to announce that its strategic down-stream retail partner Inner Spirit Holdings Ltd. ("Inner Spirit"), has received all of the necessary exchange and regulatory approvals to commence trading publicly on the Canadian Securities Exchange under the symbol “ISH” as of August 1, 2018. Pursuant to the requirements of National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and applicable Canadian securities legislation, Auxly announces that in connection with the completion by Inner Spirit of its initial public offering on July 31, 2018 (the "IPO"), Auxly has acquired 7,058,824 units of Inner Spirit, with each unit consisting of one common share of Inner Spirit (each a "Common Share") and one-half of one Common Share purchase warrant of Inner Spirit (for a total of 3,529,412 warrants) in consideration for an aggregate purchase price of $1,058,823.60, with each warrant entitling the holder to purchase one Common Share at an exercise price of $0.30 per Common Share for a period of 24 months from the date of issuance.

  • GlobeNewswire3 months ago

    Auxly Announces Listing of Warrants

    VANCOUVER, British Columbia, July 27, 2018-- Auxly Cannabis Group Inc. is pleased to announce that it has received the approval of the TSX Venture Exchange for the listing of 32,200,000 common share purchase ...